| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | |
| Div Cover | n/a | |
| Op Mrgn | 1.4% | |
| ROCE | 9.8% |
| Latest | F'cast | |
|---|---|---|
| P/E | 634.8 | |
| PEG | n/a | |
| Pr/Revenue | 4.6 | |
| Pr/Book | 5.6 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 14.8% | |
| PBT | -62.0% | |
| EPS | -94.0% | |
| DPS | n/a |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | 2,666.70 | (232.22) | (136.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-21 | 2,986.27 | 570.44 | 430.00¢ | 17.1 | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | 3,394.64 | 529.12 | 153.00¢ | 52.5 | n/a | -64% | n/a | 0.0% |
| 31-Dec-23 | 3,695.65 | 834.22 | 267.00¢ | 23.5 | 0.3 | +74% | n/a | 0.0% |
| 31-Dec-24 | 4,241.22 | 316.63 | 16.00¢ | 431.7 | n/a | -94% | n/a | 0.0% |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-25 | 4,954.27 | 1,609.46 | 672.64¢ | 15.1 | 0.0 | +4,104% | n/a | 0.0% |
| 31-Dec-26 | 5,470.98 | 1,920.92 | 771.90¢ | 13.2 | 0.9 | +15% | n/a | 0.0% |
| 31-Dec-27 | 5,972.39 | 2,218.18 | 876.28¢ | 11.6 | 0.9 | +14% | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
| FDA grants EUA for Eli Lilly treatment in conjun... | 20-Nov-2020 | ShareCast |
| Currency | US Dollars |
| Share Price | $ 101.57 |
| Closing Price Change | $ 8.09 |
| % Change | 0.00 % |
| 52 Week High | $0.00 |
| 52 Week Low | $0.00 |
| Volume | 0 |
| Shares Issued | 193.43m |
| RiskGrade | 196 |
| Strong Buy | 6 |
| Buy | 4 |
| Neutral | 12 |
| Sell | 2 |
| Strong Sell | 0 |
| Total | 24 |

You are here: research